ARTICLE | Clinical News
Amoxicillin clavulanate regulatory update
January 11, 2010 8:00 AM UTC
Ranbaxy's Ohm Laboratories Inc. unit received a warning letter from FDA citing certain current good manufacturing practices (cGMP) violations at the company's liquid manufacturing facility in Gloversv...